New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Targeted cancer drug made available for some NHS liver cancer patients

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people
Oncology March 09,2024
Targeted cancer drug made available for some NHS liver cancer patients

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people
Oncology March 09,2024
Potential markers identified for early detection and prevention of liver cancer

Potential markers identified for early detection and prevention of liver cancer

by FrontiersCredit: CC0 Public DomainLiver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cur
Oncology March 09,2024
Potential markers identified for early detection and prevention of liver cancer

Potential markers identified for early detection and prevention of liver cancer

by FrontiersCredit: CC0 Public DomainLiver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cur
Oncology March 09,2024
Pancreatic tumors may require a one-two-three punch

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s
Oncology March 09,2024
Pancreatic tumors may require a one-two-three punch

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s
Oncology March 09,2024
A step forward in the struggle against neuroblastoma, a type of childhood cancer

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish
Oncology March 09,2024
A step forward in the struggle against neuroblastoma, a type of childhood cancer

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish
Oncology March 09,2024
Genetic causes of tumors in salivary glands

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl
Oncology March 09,2024
Genetic causes of tumors in salivary glands

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl
Oncology March 09,2024
Washington University will open second proton center for cancer treatment as others shut down

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&
Oncology March 09,2024
Washington University will open second proton center for cancer treatment as others shut down

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&
Oncology March 09,2024
Current PSA monitoring ignores risk to some prostate cancer survivors

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
Oncology March 09,2024
Current PSA monitoring ignores risk to some prostate cancer survivors

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
Oncology March 09,2024
Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers with members affiliated with multiple institutions in The Netherlands and Australia has conducted the largest-ever whole-gen
Oncology March 09,2024
Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers with members affiliated with multiple institutions in The Netherlands and Australia has conducted the largest-ever whole-gen
Oncology March 09,2024
Only a third of women take up all offered cancer screenings, new research finds

Only a third of women take up all offered cancer screenings, new research finds

by King's College LondonCredit: CC0 Public DomainIn a paper published today in theJournal of Medical Screening, researchers from King's College London and Queen Mary University of L
Oncology March 09,2024
Only a third of women take up all offered cancer screenings, new research finds

Only a third of women take up all offered cancer screenings, new research finds

by King's College LondonCredit: CC0 Public DomainIn a paper published today in theJournal of Medical Screening, researchers from King's College London and Queen Mary University of L
Oncology March 09,2024
In high-risk neuroblastoma, two stem cell transplants may be better than one

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of
Oncology March 09,2024
In high-risk neuroblastoma, two stem cell transplants may be better than one

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of
Oncology March 09,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com